Smith & Nephew plc logo

Smith & Nephew plc

TickerSN.LVenueLSESectorHealthcarePrimary listingBeta0.69
1,074pGBX-0.97%
FinScore66

Smith & Nephew plc is a United Kingdom-based company in the Healthcare sector with a market capitalisation of $12.1B. Its FinScore is 66/100; its highest-scoring layer is Quality (72) and its lowest is Growth (48). The shares trade at 18.8x trailing earnings and are down 11% year to date.

Market cap
$12.1B
P/E (TTM)
18.8x
Dividend yield (TTM)
2.68%
ROE
12.2%

Share price performance

Loading chart…

About Smith & Nephew plc

www.smith-nephew.com

Smith & Nephew plc, along with its subsidiaries, operates globally as a developer, manufacturer, marketer, and seller of medical technology. Its orthopaedic division offers knee implants for replacement procedures and hip implants for joint reconstruction. This segment also provides trauma and extremities products, including internal and external fixation devices crucial for stabilizing severe fractures and correcting deformities. In the sports medicine field, the company furnishes surgeons with comprehensive joint repair solutions. These encompass specialized instruments, advanced technologies, and implants necessary for minimally invasive joint surgeries, addressing soft tissue injuries and degenerative conditions of the knee, hip, and shoulder, as well as meniscal repair systems. Additionally, its arthroscopic enabling technologies support surgical visualization and intervention inside joints, comprising fluid management equipment, high-definition cameras, digital image capture systems, scopes, light sources, and monitors. It also supplies radiofrequency, electromechanical, and mechanical tissue resection devices, along with hand instruments for removing damaged tissue, and provides ear, nose, and throat (ENT) solutions. Furthermore, Smith & Nephew delivers sophisticated advanced wound management solutions. This category features products for the treatment and prevention of acute and chronic wounds, including leg, diabetic, and pressure ulcers, burns, and post-operative wounds. Its offerings extend to advanced wound bioactives, incorporating biologics and other active technologies for debridement, dermal repair, and regeneration, as well as regenerative medicine products like skin, bone graft, and articular cartilage substitutes. The advanced wound devices portfolio includes traditional and single-use negative pressure wound therapy systems, alongside hydrosurgery devices. Primarily serving healthcare providers, Smith & Nephew plc was founded in 1856 and maintains its corporate headquarters in Watford, United Kingdom.

Profile
Sector
Healthcare
Industry
Medical - Devices
HQ
United Kingdom
Fiscal year-end
December
Trading currency
GBP
Reporting currency
USD
Fundamentals updated
75 days ago
Market
Market cap
$12.1B
Shares outstanding
837.0M
P/E (TTM)
18.8x
Dividend yield (TTM)
2.68%
Beta (issuer)
0.69
Revenue (latest FY)
$6.3B

Revenue breakdown

FY 2025$6.2B
  • Orthopaedics, Sports Medicine and Ear Nose and Throat
    70.9%$4.4B
  • Advanced Wound Management
    29.1%$1.8B

FinScore

As of 2026-10-19
Overall66
Quality72
Growth48
Value72
Momentum58
Relative Strength88

Snapshot

Ownership

As of 2026-03-31
Institutional
2.0%
Insider
—
Free float
97.7%
Top-5 institutional holders
2.0%
Shares outstanding
837.0M
Sign up to see the top holders

Sign up or log in to see Analysis

Analysis for Smith & Nephew plc is available to Finryse members. The Overview stays open to everyone; creating an account is free.

Sign up or log in to see Financials

Financials for Smith & Nephew plc is available to Finryse members. The Overview stays open to everyone; creating an account is free.

Sign up or log in to see Estimates

Estimates for Smith & Nephew plc is available to Finryse members. The Overview stays open to everyone; creating an account is free.

Sign up or log in to see Peers

Peers for Smith & Nephew plc is available to Finryse members. The Overview stays open to everyone; creating an account is free.

Sign up or log in to see Valuation

Valuation for Smith & Nephew plc is available to Finryse members. The Overview stays open to everyone; creating an account is free.

Sign up or log in to see News

News for Smith & Nephew plc is available to Finryse members. The Overview stays open to everyone; creating an account is free.